Investigating the effect of valsartan sacubitril on left ventricular functio
Phase 2
Recruiting
- Conditions
- Ischemic Heart Disease.Other acute ischemic heart diseases
- Registration Number
- IRCT20240117060713N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 92
Inclusion Criteria
Consent to participate in the study
Heart failure patients with LVEF less than 40
Coronary Artery Disease
History of angioplasty
Coronary artery bypass surgery
Exclusion Criteria
Insulin-dependent diabetes mellitus
respiratory diseases
Chronic kidney diseases
Uncontrolled blood pressure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eft Ventricular Ejection Fraction. Timepoint: Before and after 6 months of intervention. Method of measurement: Echocardiography.;Left ventricular end-diastolic volume. Timepoint: Before and after 6 months of intervention. Method of measurement: Echocardiography.;Left Ventricular End-Systolic Volume. Timepoint: Before and after 6 months of intervention. Method of measurement: Echocardiography.
- Secondary Outcome Measures
Name Time Method Duration of hospitalization. Timepoint: After 6 months of intervention. Method of measurement: Examination of patient records.;Mortality. Timepoint: After 6 months of intervention. Method of measurement: Examination of patient records.